United States Biotechnology & Medical Research

Voyager Therapeutics Inc (VYGR)

Track

Track

Voyager Therapeutics Inc. experienced significant selling activity recently, with executives offloading shares totaling over $136,000. These transactions occurred amid a 24.5% decline in stock price over the last quarter. Despite a positive earnings report showing a 27% EPS beat, leadership and former officers consistently reduced their equity stakes throughout early 2026.
Ticker: VYGR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Voyager Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Jorgensen Nathan D. Former Officer Officer
Transaction date
Proposed sale
Price
463.15
Quantity 85,450
Value US$2,209,389
2.9
Jorgensen Nathan D. Former Officer Officer
Transaction date
Proposed sale
Price
59.34
Quantity 21,953
Value US$3,101,619
3.0
Sandrock Alfred President and CEO Executive Director
Transaction date
Sale
Price
284.74
Quantity 38,295 -46.2%
Value US$2,093,027
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.87
Quantity 11,511
Value US$44,597
2.7
Swartz Robin COO & CBO Officer
Transaction date
Sale
Price
3.77
Quantity 6,458 -3.1%
Value US$24,347
3.0
Sandrock Alfred President and CEO Executive Director
Transaction date
Sale
Price
3.79
Quantity 14,197 -2.8%
Value US$53,807
2.9
Jorgensen Nathan D. Chief Financial Officer Officer
Transaction date
Sale
Price
3.77
Quantity 4,668 -3.0%
Value US$17,598
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
3.76
Quantity 4,174 -2.8%
Value US$15,694
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
3.76
Quantity 4,174
Value US$15,711
2.9
Jorgensen Nathan D. Officer Officer
Transaction date
Proposed sale
Price
3.77
Quantity 4,668
Value US$17,588
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
3.77
Quantity 6,458
Value US$24,335
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.79
Quantity 14,197
Value US$53,852
2.7
Swartz Robin COO & CBO Officer
Transaction date
Sale
Price
3.44
Quantity 3,882 -1.8%
Value US$13,354
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
3.44
Quantity 3,301 -2.2%
Value US$11,355
3.0
Sandrock Alfred President and CEO Executive Director
Transaction date
Sale
Price
3.41
Quantity 11,732 -2.3%
Value US$40,006
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.41
Quantity 11,732
Value US$40,039
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
3.44
Quantity 3,301
Value US$11,346
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
3.44
Quantity 3,882
Value US$13,349
2.7
Swartz Robin COO & CBO Officer
Transaction date
Sale
Price
3.85
Quantity 4,569 -2.1%
Value US$17,591
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
3.85
Quantity 3,525 -2.2%
Value US$13,571
3.0
Sandrock Alfred President and CEO Executive Director
Transaction date
Sale
Price
3.78
Quantity 12,192 -2.3%
Value US$46,086
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.78
Quantity 12,192
Value US$46,093
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
3.85
Quantity 4,569
Value US$17,599
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
3.84
Quantity 3,525
Value US$13,553
2.9
Jorgensen Nathan D. Chief Financial Officer Officer
Transaction date
Sale
Price
4.78
Quantity 7,666 -5.8%
Value US$36,643
2.9
Jorgensen Nathan D. Officer Officer
Transaction date
Proposed sale
Price
4.78
Quantity 7,666
Value US$36,634
1.6
Ferguson Toby Chief Medical Officer Officer
Transaction date
Sale
Price
3.73
Quantity 19,000 -12.0%
Value US$70,870
1.6
Ferguson Toby Officer Officer
Transaction date
Proposed sale
Price
3.72
Quantity 19,000
Value US$70,680
1.6
Ferguson Toby Chief Medical Officer Officer
Transaction date
Sale
Price
3.43
Quantity 10,086 -6.0%
Value US$34,595
3.0
Sandrock Alfred President and CEO Executive Director
Transaction date
Sale
Price
3.43
Quantity 10,885 -2.5%
Value US$37,336
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.43
Quantity 10,885
Value US$37,369
1.6
Ferguson Toby Officer Officer
Transaction date
Proposed sale
Price
3.43
Quantity 10,086
Value US$34,624
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
4.26
Quantity 3,305 -4.1%
Value US$14,079
3.0
Sandrock Alfred President and CEO Executive Director
Transaction date
Sale
Price
4.24
Quantity 11,702 -3.8%
Value US$49,616
2.7
Swartz Robin COO & CBO Officer
Transaction date
Sale
Price
4.25
Quantity 3,894 -3.8%
Value US$16,550
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.24
Quantity 11,702
Value US$49,666
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
4.26
Quantity 3,305
Value US$14,075
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
4.25
Quantity 3,894
Value US$16,557
2.7
Swartz Robin COO & CBO Officer
Transaction date
Sale
Price
4.45
Quantity 6,950 -6.4%
Value US$30,928
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
4.45
Quantity 5,413 -6.3%
Value US$24,088
3.0
Sandrock Alfred President & CEO Officer
Transaction date
Planned sale
Price
4.45
Quantity 16,644 -5.1%
Value US$74,066
2.8
Fahey Sandell Jacquelyn Chief Legal Officer Officer
Transaction date
Sale
Price
4.45
Quantity 4,358 -5.1%
Value US$19,393
2.8
Fahey Sandell Jacquelyn Officer Officer
Transaction date
Proposed sale
Price
4.45
Quantity 4,358
Value US$19,412
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
4.45
Quantity 5,413
Value US$24,110
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.45
Quantity 16,644
Value US$74,046
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
4.45
Quantity 6,950
Value US$30,938
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
5.13
Quantity 1,191 -1.4%
Value US$6,110
2.7
Swartz Robin COO & CBO Officer
Transaction date
Sale
Price
5.09
Quantity 3,087 -2.7%
Value US$15,713
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
5.09
Quantity 3,087
Value US$15,721
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
5.13
Quantity 1,191
Value US$6,106
2.7
Swartz Robin COO&CBO Officer
Transaction date
Planned sale
Price
5.65
Quantity 6,500 -5.5%
Value US$36,725
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
5.65
Quantity 6,500
Value US$36,747
2.8
Fahey Sandell Jacquelyn Chief Legal Officer Officer
Transaction date
Sale
Price
5.82
Quantity 5,999 -6.5%
Value US$34,914
3.0
Sandrock Alfred President and CEO Executive Director
Transaction date
Sale
Price
9.86
Quantity 12,115 -3.6%
Value US$119,454
2.7
Swartz Robin Chief Operating Officer Officer
Transaction date
Sale
Price
9.88
Quantity 1,357 -1.1%
Value US$13,407
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
9.88
Quantity 1,357
Value US$13,414
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.86
Quantity 12,115
Value US$119,507
3.0
Sandrock Alfred President and CEO Executive Director
Transaction date
Sale
Price
7.46
Quantity 13,033 -3.7%
Value US$97,226
3.3
PFREUNDSCHUH PETER P. Chief Financial Officer Officer
Transaction date
Sale
Price
7.46
Quantity 3,764 -2.1%
Value US$28,079
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
7.47
Quantity 3,365 -3.7%
Value US$25,137
2.7
Swartz Robin Chief Operating Officer Officer
Transaction date
Sale
Price
7.45
Quantity 3,966 -3.2%
Value US$29,547
3.0
Sandrock Alfred Officer; Director Executive Director
Transaction date
Proposed sale
Price
7.46
Quantity 13,033
Value US$97,207
3.3
PFREUNDSCHUH PETER P. Officer Officer
Transaction date
Proposed sale
Price
7.46
Quantity 3,764
Value US$28,076
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
7.45
Quantity 3,966
Value US$29,557
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
7.47
Quantity 3,365
Value US$25,122
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
7.68
Quantity 602 -0.7%
Value US$4,623
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
7.68
Quantity 602
Value US$4,622
2.9
Carter Todd Alfred Chief Scientific Officer Officer
Transaction date
Sale
Price
7.18
Quantity 1,266 -2.3%
Value US$9,090
2.7
Swartz Robin Chief Operating Officer Officer
Transaction date
Planned sale
Price
7.15
Quantity 2,543 -3.4%
Value US$18,182
2.7
Swartz Robin Officer Officer
Transaction date
Proposed sale
Price
7.15
Quantity 2,543
Value US$18,170
2.9
Carter Todd Alfred Officer Officer
Transaction date
Proposed sale
Price
7.18
Quantity 1,266
Value US$9,088
3.3
PFREUNDSCHUH PETER P. Chief Financial Officer Officer
Transaction date
Sale
Price
6.99
Quantity 13,567 -8.3%
Value US$94,833
3.3
PFREUNDSCHUH PETER P. Officer Officer
Transaction date
Proposed sale
Price
6.99
Quantity 13,567
Value US$94,784
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-15 2026-05-15 PrS Proposed sale
2.9
Jorgensen Nathan D.

Former Officer

Officer
85,450
463.15
US$2,209,389 		85,450 463.15 US$2,209,389
2026-05-15 2026-05-15 PrS Proposed sale
2.9
Jorgensen Nathan D.

Former Officer

Officer
21,953
59.34
US$3,101,619 		21,953 59.34 US$3,101,619
2026-04-03 2026-04-02 S Sale
3.0
Sandrock Alfred

President and CEO

Executive Director
38,295 -46.2%
284.74
US$2,093,027 		38,295 -46.2% 284.74 US$2,093,027
2026-04-02 2026-04-02 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
11,511
3.87
US$44,597 		11,511 3.87 US$44,597
2026-02-26 2026-02-24 S Sale
2.7
Swartz Robin

COO & CBO

Officer
6,458 -3.1%
3.77
US$24,347 		6,458 -3.1% 3.77 US$24,347
2026-02-26 2026-02-24 S Sale
3.0
Sandrock Alfred

President and CEO

Executive Director
14,197 -2.8%
3.79
US$53,807 		14,197 -2.8% 3.79 US$53,807
2026-02-26 2026-02-24 S Sale
2.9
Jorgensen Nathan D.

Chief Financial Officer

Officer
4,668 -3.0%
3.77
US$17,598 		4,668 -3.0% 3.77 US$17,598
2026-02-26 2026-02-24 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
4,174 -2.8%
3.76
US$15,694 		4,174 -2.8% 3.76 US$15,694
2026-02-24 2026-02-24 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
4,174
3.76
US$15,711 		4,174 3.76 US$15,711
2026-02-24 2026-02-24 PrS Proposed sale
2.9
Jorgensen Nathan D.

Officer

Officer
4,668
3.77
US$17,588 		4,668 3.77 US$17,588
2026-02-24 2026-02-24 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
6,458
3.77
US$24,335 		6,458 3.77 US$24,335
2026-02-24 2026-02-24 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
14,197
3.79
US$53,852 		14,197 3.79 US$53,852
2026-02-20 2026-02-18 S Sale
2.7
Swartz Robin

COO & CBO

Officer
3,882 -1.8%
3.44
US$13,354 		3,882 -1.8% 3.44 US$13,354
2026-02-20 2026-02-18 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
3,301 -2.2%
3.44
US$11,355 		3,301 -2.2% 3.44 US$11,355
2026-02-20 2026-02-18 S Sale
3.0
Sandrock Alfred

President and CEO

Executive Director
11,732 -2.3%
3.41
US$40,006 		11,732 -2.3% 3.41 US$40,006
2026-02-18 2026-02-18 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
11,732
3.41
US$40,039 		11,732 3.41 US$40,039
2026-02-18 2026-02-18 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
3,301
3.44
US$11,346 		3,301 3.44 US$11,346
2026-02-18 2026-02-18 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
3,882
3.44
US$13,349 		3,882 3.44 US$13,349
2026-02-11 2026-02-10 S Sale
2.7
Swartz Robin

COO & CBO

Officer
4,569 -2.1%
3.85
US$17,591 		4,569 -2.1% 3.85 US$17,591
2026-02-11 2026-02-10 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
3,525 -2.2%
3.85
US$13,571 		3,525 -2.2% 3.85 US$13,571
2026-02-11 2026-02-10 S Sale
3.0
Sandrock Alfred

President and CEO

Executive Director
12,192 -2.3%
3.78
US$46,086 		12,192 -2.3% 3.78 US$46,086
2026-02-10 2026-02-10 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
12,192
3.78
US$46,093 		12,192 3.78 US$46,093
2026-02-10 2026-02-10 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
4,569
3.85
US$17,599 		4,569 3.85 US$17,599
2026-02-10 2026-02-10 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
3,525
3.84
US$13,553 		3,525 3.84 US$13,553
2025-10-07 2025-10-03 S Sale
2.9
Jorgensen Nathan D.

Chief Financial Officer

Officer
7,666 -5.8%
4.78
US$36,643 		7,666 -5.8% 4.78 US$36,643
2025-10-03 2025-10-03 PrS Proposed sale
2.8
Fahey Sandell Jacquelyn

Officer

Officer
5,843
4.78
US$27,937 		5,843 4.78 US$27,937
2025-10-03 2025-10-03 PrS Proposed sale
2.9
Jorgensen Nathan D.

Officer

Officer
7,666
4.78
US$36,634 		7,666 4.78 US$36,634
2025-08-20 2025-08-18 S Sale
1.6
Ferguson Toby

Chief Medical Officer

Officer
19,000 -12.0%
3.73
US$70,870 		19,000 -12.0% 3.73 US$70,870
2025-08-18 2025-08-18 PrS Proposed sale
1.6
Ferguson Toby

Officer

Officer
19,000
3.72
US$70,680 		19,000 3.72 US$70,680
2025-04-04 2025-04-02 S Sale
1.6
Ferguson Toby

Chief Medical Officer

Officer
10,086 -6.0%
3.43
US$34,595 		10,086 -6.0% 3.43 US$34,595
2025-04-04 2025-04-02 S Sale
3.0
Sandrock Alfred

President and CEO

Executive Director
10,885 -2.5%
3.43
US$37,336 		10,885 -2.5% 3.43 US$37,336
2025-04-02 2025-04-02 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
10,885
3.43
US$37,369 		10,885 3.43 US$37,369
2025-04-02 2025-04-02 PrS Proposed sale
1.6
Ferguson Toby

Officer

Officer
10,086
3.43
US$34,624 		10,086 3.43 US$34,624
2025-02-24 2025-02-20 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
3,305 -4.1%
4.26
US$14,079 		3,305 -4.1% 4.26 US$14,079
2025-02-24 2025-02-20 S Sale
3.0
Sandrock Alfred

President and CEO

Executive Director
11,702 -3.8%
4.24
US$49,616 		11,702 -3.8% 4.24 US$49,616
2025-02-24 2025-02-20 S Sale
2.7
Swartz Robin

COO & CBO

Officer
3,894 -3.8%
4.25
US$16,550 		3,894 -3.8% 4.25 US$16,550
2025-02-20 2025-02-20 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
11,702
4.24
US$49,666 		11,702 4.24 US$49,666
2025-02-20 2025-02-20 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
3,305
4.26
US$14,075 		3,305 4.26 US$14,075
2025-02-20 2025-02-20 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
3,894
4.25
US$16,557 		3,894 4.25 US$16,557
2025-02-12 2025-02-11 S Sale
2.7
Swartz Robin

COO & CBO

Officer
6,950 -6.4%
4.45
US$30,928 		6,950 -6.4% 4.45 US$30,928
2025-02-12 2025-02-11 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
5,413 -6.3%
4.45
US$24,088 		5,413 -6.3% 4.45 US$24,088
2025-02-12 2025-02-11 PlS Planned sale
3.0
Sandrock Alfred

President & CEO

Officer
16,644 -5.1%
4.45
US$74,066 		16,644 -5.1% 4.45 US$74,066
2025-02-12 2025-02-11 S Sale
2.8
Fahey Sandell Jacquelyn

Chief Legal Officer

Officer
4,358 -5.1%
4.45
US$19,393 		4,358 -5.1% 4.45 US$19,393
2025-02-11 2025-02-11 PrS Proposed sale
2.8
Fahey Sandell Jacquelyn

Officer

Officer
4,358
4.45
US$19,412 		4,358 4.45 US$19,412
2025-02-11 2025-02-11 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
5,413
4.45
US$24,110 		5,413 4.45 US$24,110
2025-02-11 2025-02-11 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
16,644
4.45
US$74,046 		16,644 4.45 US$74,046
2025-02-11 2025-02-11 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
6,950
4.45
US$30,938 		6,950 4.45 US$30,938
2025-01-15 2025-01-14 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
1,191 -1.4%
5.13
US$6,110 		1,191 -1.4% 5.13 US$6,110
2025-01-15 2025-01-14 S Sale
2.7
Swartz Robin

COO & CBO

Officer
3,087 -2.7%
5.09
US$15,713 		3,087 -2.7% 5.09 US$15,713
2025-01-14 2025-01-14 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
3,087
5.09
US$15,721 		3,087 5.09 US$15,721
2025-01-14 2025-01-14 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
1,191
5.13
US$6,106 		1,191 5.13 US$6,106
2024-12-26 2024-12-23 PlS Planned sale
2.7
Swartz Robin

COO&CBO

Officer
6,500 -5.5%
5.65
US$36,725 		6,500 -5.5% 5.65 US$36,725
2024-12-23 2024-12-23 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
6,500
5.65
US$36,747 		6,500 5.65 US$36,747
2024-10-03 2024-10-02 S Sale
2.8
Fahey Sandell Jacquelyn

Chief Legal Officer

Officer
5,999 -6.5%
5.82
US$34,914 		5,999 -6.5% 5.82 US$34,914
2024-10-02 2024-10-02 PrS Proposed sale
2.8
Fahey Sandell Jacquelyn

Officer

Officer
5,999
5.82
US$34,920 		5,999 5.82 US$34,920
2024-04-03 2024-04-02 S Sale
3.0
Sandrock Alfred

President and CEO

Executive Director
12,115 -3.6%
9.86
US$119,454 		12,115 -3.6% 9.86 US$119,454
2024-04-03 2024-04-02 S Sale
2.7
Swartz Robin

Chief Operating Officer

Officer
1,357 -1.1%
9.88
US$13,407 		1,357 -1.1% 9.88 US$13,407
2024-04-02 2024-04-02 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
1,357
9.88
US$13,414 		1,357 9.88 US$13,414
2024-04-02 2024-04-02 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
12,115
9.86
US$119,507 		12,115 9.86 US$119,507
2024-02-22 2024-02-21 S Sale
3.0
Sandrock Alfred

President and CEO

Executive Director
13,033 -3.7%
7.46
US$97,226 		13,033 -3.7% 7.46 US$97,226
2024-02-22 2024-02-21 S Sale
3.3
PFREUNDSCHUH PETER P.

Chief Financial Officer

Officer
3,764 -2.1%
7.46
US$28,079 		3,764 -2.1% 7.46 US$28,079
2024-02-22 2024-02-21 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
3,365 -3.7%
7.47
US$25,137 		3,365 -3.7% 7.47 US$25,137
2024-02-22 2024-02-21 S Sale
2.7
Swartz Robin

Chief Operating Officer

Officer
3,966 -3.2%
7.45
US$29,547 		3,966 -3.2% 7.45 US$29,547
2024-02-21 2024-02-21 PrS Proposed sale
3.0
Sandrock Alfred

Officer; Director

Executive Director
13,033
7.46
US$97,207 		13,033 7.46 US$97,207
2024-02-21 2024-02-21 PrS Proposed sale
3.3
PFREUNDSCHUH PETER P.

Officer

Officer
3,764
7.46
US$28,076 		3,764 7.46 US$28,076
2024-02-21 2024-02-21 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
3,966
7.45
US$29,557 		3,966 7.45 US$29,557
2024-02-21 2024-02-21 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
3,365
7.47
US$25,122 		3,365 7.47 US$25,122
2024-02-22 2024-02-20 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
602 -0.7%
7.68
US$4,623 		602 -0.7% 7.68 US$4,623
2024-02-20 2024-02-20 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
602
7.68
US$4,622 		602 7.68 US$4,622
2024-01-19 2024-01-17 S Sale
2.9
Carter Todd Alfred

Chief Scientific Officer

Officer
1,266 -2.3%
7.18
US$9,090 		1,266 -2.3% 7.18 US$9,090
2024-01-19 2024-01-17 PlS Planned sale
2.7
Swartz Robin

Chief Operating Officer

Officer
2,543 -3.4%
7.15
US$18,182 		2,543 -3.4% 7.15 US$18,182
2024-01-17 2024-01-17 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
2,543
7.15
US$18,170 		2,543 7.15 US$18,170
2024-01-17 2024-01-17 PrS Proposed sale
2.9
Carter Todd Alfred

Officer

Officer
1,266
7.18
US$9,088 		1,266 7.18 US$9,088
2023-10-05 2023-10-03 S Sale
3.3
PFREUNDSCHUH PETER P.

Chief Financial Officer

Officer
13,567 -8.3%
6.99
US$94,833 		13,567 -8.3% 6.99 US$94,833
2023-10-03 2023-10-03 PrS Proposed sale
3.3
PFREUNDSCHUH PETER P.

Officer

Officer
13,567
6.99
US$94,784 		13,567 6.99 US$94,784
Explore more

More insider trading research around Voyager Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America